Valeant Teams With Bill Ackman to Buy Allergan
April 23 (Bloomberg) -- Valeant offered to buy Allergan for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment. Stephanie Ruhle reports on Bill Ackman’s involvement on Bloomberg Television’s “In The Loop.” (Source: Bloomberg)
Most Recent Videos
Soylent: The Food of the Future?
13:09 - Rob Rhinehart, Soylent's chief executive officer, discusses the company's quest to disrupt the food industry. He speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)